HYUNDAI BIOLAND Co.,Ltd. Logo

HYUNDAI BIOLAND Co.,Ltd.

Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.

052260 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HYUNDAI BIOLAND Co., Ltd. is a comprehensive healthcare and biotechnology company specializing in the research, development, and manufacturing of biomaterials derived from natural resources. The company's core business operates across three main sectors: cosmetics, nutraceuticals (health supplements), and regenerative medicine. It is a key supplier of raw materials, including collagen and hyaluronic acid, to the cosmetics industry. In the nutraceuticals field, it provides functional ingredients for health foods. For the biomedical market, the company develops medical devices such as resorbable membranes for dental and periodontal tissue regeneration. Leveraging its position as a leading natural materials company in Korea, Hyundai Bioland distributes its products to over 35 countries, with safety certifications in 33 nations.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HYUNDAI BIOLAND Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOLAND Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HYUNDAI BIOLAND Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea 176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea 180400
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea 044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan 4549

Talk to a Data Expert

Have a question? We'll get back to you promptly.